Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia

Diabetes Care. 1999 Jul;22(7):1224-5. doi: 10.2337/diacare.22.7.1224.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Blood Flow Velocity / drug effects
  • Brachial Artery / drug effects
  • Brachial Artery / physiopathology
  • Cholesterol / blood
  • Cholesterol, LDL / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Endothelium, Vascular / physiopathology*
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / physiopathology*
  • Reference Values
  • Simvastatin / therapeutic use*
  • Time Factors

Substances

  • Anticholesteremic Agents
  • Cholesterol, LDL
  • Cholesterol
  • Simvastatin